I recently came back from this year’s Oracle Health Sciences Connect in Philadelphia. I found myself inspired by both the event’s scope and the ideas exchanged there.
Nearly 300 customers from the life sciences and healthcare sectors attended our event. Attendees represented 85 leading companies, including the top pharmas, biotechs, CROs, medical device organizations, and more.
One reason that all these people came together was that they share a need in common. They all require data-driven insights for faster, better, and more profitable decisions in an industry that’s becoming more dependent on the aggregation and analysis of diverse data streams every day.
Oracle Health Sciences SVP and General Manager, Steve Rosenberg, kicked off the event with an insightful keynote on the advances in clinical research and how the right systems enable companies to “simplify, accelerate, empower, and unify” tasks. “It’s a different way of thinking about the systems to conduct clinical research, a different way of going about people’s jobs,” he said, “One that will significantly improve the way clinical research is being done.”
During the event, attendees chose from three separate discussion tracks and 31 sessions -- nearly double the number of last year’s event -- addressing many of the numerous advances that Steve mentioned.
Our sessions covered topics in safety, clinical trial operations, data management, the future of clinical trials, study startup, and more. For example, in the area of safety, discussions circled around the importance of artificial intelligence in safety case management and the role that data management technology plays in compliance and multivigilance across the product lifecycle.
Attendees heard about the increasingly central role digital clinical trials will play, as well as the overall future of digital health, thanks to the Internet of Things adding a wealth of patient and environmental data to more traditional information sources.
Our guests also saw demonstrations of technology in action to simplify, accelerate, empower, and unify tasks. For example, Oracle’s VP of Product Management, Andrea Sim, gave a provocative talk and demonstration of how clinical teams can streamline and improve the complex task of site selection for clinical trials.
Today, most CTOs have to manage and organize unstandardized data from different sources to make vital decisions. Instead of using common manual or home-grown methods, Oracle Health Sciences can pull all kinds of structured and unstructured data together with one set of tools and present it in a single dashboard.
In another packed session, Oracle’s Andy Alasso, Liam Wood, and I demonstrated the key features of Oracle Health Sciences Clinical One and how it serves as the unified data source for every aspect of modern clinical trials.
Later, Kristen Striffler, associate director of clinical development for Oyster Point Pharma, described how Clinical One supercharged the randomization and drug supply setup for a trial testing a compound to treat dry eye disease. “This is one of the fastest IRT startups I’ve had in my career,” she said. “We actually saw the UAT [user acceptance testing] and the testing site in a matter of days.”
It’s not only the work of the clinical trial team that’s changing. So, too, is the experience of patient participating trial. Derek Pollock, managing director of Accenture, reminded the audience of the importance of patient centricity, and how focusing on the individual along with the clinical trial data can enable better clinical trial outcomes. “Every time we talk about a subject in a clinical trial, I think ‘patients’ because they are persons, and the more we understand about them as persons, the more successful we will be,” he said.
If you didn’t get a chance to attend Oracle Health Sciences Connect, there’s a lot more to review from this year’s event on our social channels and the website.
I hope you’ll find it as exciting as I did, make plans to learn more about how our technology can advance clinical trials, and plan to attend next year’s event.
Contact us for a conversation about clinical trials and your future research plans.